- Home
- TXG vs BLFS Comparison
TXG vs BLFS Comparison
Compare TXG & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- BLFS
- Stock Information
- Founded
- TXG 2012
- BLFS 1987
- Country
- TXG United States
- BLFS United States
- Employees
- TXG N/A
- BLFS N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- BLFS Medical/Dental Instruments
- Sector
- TXG Industrials
- BLFS Health Care
- Exchange
- TXG Nasdaq
- BLFS Nasdaq
- Market Cap
- TXG 1.6B
- BLFS 1.3B
- IPO Year
- TXG 2019
- BLFS 1989
- Fundamental
- Price
- TXG $15.93
- BLFS $24.30
- Analyst Decision
- TXG Buy
- BLFS Strong Buy
- Analyst Count
- TXG 13
- BLFS 5
- Target Price
- TXG $14.50
- BLFS $30.60
- AVG Volume (30 Days)
- TXG 3.2M
- BLFS 325.8K
- Earning Date
- TXG 11-06-2025
- BLFS 11-06-2025
- Dividend Yield
- TXG N/A
- BLFS N/A
- EPS Growth
- TXG N/A
- BLFS N/A
- EPS
- TXG N/A
- BLFS N/A
- Revenue
- TXG $641,814,000.00
- BLFS $100,144,000.00
- Revenue This Year
- TXG $2.07
- BLFS $25.65
- Revenue Next Year
- TXG N/A
- BLFS $14.81
- P/E Ratio
- TXG N/A
- BLFS N/A
- Revenue Growth
- TXG 1.92
- BLFS 87.53
- 52 Week Low
- TXG $6.78
- BLFS $19.10
- 52 Week High
- TXG $17.70
- BLFS $29.62
- Technical
- Relative Strength Index (RSI)
- TXG 62.12
- BLFS 32.92
- Support Level
- TXG $12.80
- BLFS $25.49
- Resistance Level
- TXG $17.70
- BLFS $28.21
- Average True Range (ATR)
- TXG 0.97
- BLFS 1.01
- MACD
- TXG 0.30
- BLFS -0.40
- Stochastic Oscillator
- TXG 66.79
- BLFS 4.25
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.